Latest Breaking News On - Amicus therapeutics company profile - Page 1 : comparemela.com

Hillsdale Investment Management Inc. lifted its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 8.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 294,300 shares of the biopharmaceutical company’s stock after purchasing an additional 23,640 shares during the period. Hillsdale […]

United statesMargaretg mcglynnE fund management coProfund advisorsFund management coAmicus therapeutics incJpmorgan chase coHillsdale investment management incAmicus therapeutics company profileAssociates corpMorgan stanleyNeedham companyAmicus therapeuticsHillsdale investment managementFree reportInvestment management